Julie O’Neal

Also affiliated with Jewish Hospital, BVI (United States)

MedicineBiochemistry, Genetics and Molecular BiologyMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma”.

Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma

European Journal of Nuclear Medicine and Molecular Imaging(2020)10.1007/s00259-020-05097-y

N/A

0DataRank · unranked

19 citations

Alexander Zheleznyak, Matt Mixdorf, Julie O’Neal, Julie Ritchey, Michael P. Rettig +4 more

VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2839

N/A

0DataRank · unranked

27 citations

Michael J. Scott, John S. Allen, Xiaoxia Yang, Grace Cui, Dipanjan Pan +12 more

Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy

Leukemia(2021)10.1038/s41375-021-01127-2

N/A

0DataRank · unranked

63 citations

Jennifer Sun, Katherine Wasden, Nicole Guenthner, Julie O’Neal, Barbara Muz +7 more

A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity

Nature Communications(2022)10.1038/s41467-022-30860-0

N/A

0DataRank · unranked

97 citations

Reyka G. Jayasinghe, Jessica M. Devenport, Julie Ritchey, Michael P. Rettig, Julie O’Neal +8 more

CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells

Leukemia(2022)10.1038/s41375-022-01559-4

N/A

0DataRank · unranked

55 citations

Julie Ritchey, Matthew Cooper, Jessica Niswonger, Luisalberto Gonzalez, Emily Street +12 more

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

Scientific Reports(2022)10.1038/s41598-021-03748-0

N/A

0DataRank · unranked

23 citations

Chantiya Chanswangphuwana, Nicholas S. Cho, Francesca Fontana, Dolonchampa Maji, Julie Ritchey +10 more

Liposomal phytohemagglutinin: In vivo T‐cell activator as a novel pan‐cancer immunotherapy

Journal of Cellular and Molecular Medicine(2022)10.1111/jcmm.16885

N/A

0DataRank · unranked

15 citations

Jennifer Sun, Barbara Muz, Amanda Jeske, Julie O’Neal, Julie Ritchey +4 more

Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc

Blood Advances(2023)10.1182/bloodadvances.2023010032

N/A

0DataRank · unranked

27 citations

Matthew Cooper, Julie Ritchey, Susan Gladney, Jessica Niswonger, Luisalberto Gonzalez +13 more

Traversing the bench to bedside journey for iNKT cell therapies

Frontiers in Immunology(2024)10.3389/fimmu.2024.1436968

N/A

0DataRank · unranked

10 citations

Melissa Mavers, Reyka G. Jayasinghe, John F. Dipersio, Julie O’Neal

Ablation of CD38 in multiple myeloma cells leads to an aggressive phenotype in a mouse xenograft model

Blood Advances(2025)10.1182/bloodadvances.2025017296

N/A

0DataRank · unranked

1 citations

Alexander Zheleznyak, Erin N. Teubner, Julie L. Prior, Brad Manion, Zhenghan Jing +10 more